M Gasperi Selected Research

M Gasperi Research Topics

Disease

5	Acromegaly 01/2010 - 03/2002
4	Neoplasms (Cancer) 12/2017 - 01/2003
3	Primary Hyperparathyroidism 06/2011 - 03/2002
3	Pituitary Neoplasms (Pituitary Adenoma) 10/2009 - 01/2003
3	Hypopituitarism (Sheehan's Syndrome) 07/2004 - 01/2000
2	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2010 - 09/2008
2	Adenoma (Adenomas) 10/2008 - 01/2003
2	Hypothyroidism 06/2008 - 05/2001
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2007 - 09/2006
2	Hirsutism 07/2004 - 10/2002
1	Neoplasm Metastasis (Metastasis) 12/2017
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2017
1	Multiple Sclerosis 12/2011
1	Chronic Progressive Multiple Sclerosis 12/2011
1	Vitamin D Deficiency 09/2011
1	Bone Resorption 06/2011
1	Hypercalcemia (Milk Alkali Syndrome) 06/2011
1	Prolactinoma (Prolactinomas) 10/2008
1	Body Weight (Weight, Body) 08/2008
1	Hyperplasia 07/2008
1	Thyroid Diseases (Thyroid Disease) 06/2008
1	Leukopenia 06/2008
1	type 1 familial Hypocalciuric hypercalcemia 02/2005
1	Secondary Hyperparathyroidism 02/2005
1	Joint Diseases (Joint Disease) 01/2005
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2005
1	Hyperprolactinemia 07/2004
1	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2004
1	Pituitary Diseases (Disease, Anterior Pituitary) 06/2004
1	Colonic Polyps 11/2003
1	Colonic Neoplasms (Colon Cancer) 11/2003
1	Polyps 11/2003
1	Carcinogenesis 11/2003
1	Prostatic Neoplasms (Prostate Cancer) 10/2002
1	Pituitary ACTH Hypersecretion 10/2002
1	Hypoglycemia (Reactive Hypoglycemia) 04/2002
1	Thyroiditis 05/2001
1	Tachycardia (Tachyarrhythmias) 05/2001
1	Thyrotoxicosis 05/2001
1	Combined Pituitary Hormone Deficiency 01/2000

Drug/Important Bio-Agent (IBA)

11	Insulin-Like Growth Factor I (IGF-1)IBA 12/2011 - 01/2000
5	Growth Hormone (Somatotropin)IBA 09/2010 - 03/2002
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 12/2017 - 07/2004
2	CalciumIBA 06/2011 - 02/2005
2	Amiodarone (Amiodarona)FDA LinkGeneric 06/2008 - 05/2001
2	PPAR gammaIBA 11/2005 - 11/2003
2	AndrogensIBA 07/2004 - 10/2002
1	Insulin-Like PeptidesIBA 12/2011
1	Insulin-Like Growth Factor Binding Protein 3IBA 12/2011
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 06/2011
1	Cinacalcet (Sensipar)FDA Link 06/2011
1	Diphosphonates (Bisphosphonates)IBA 06/2011
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 10/2009
1	ProlactinIBA 10/2008
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 10/2008
1	Dopamine Agonists (Dopamine Agonist)IBA 10/2008
1	Cabergoline FDA LinkGeneric 10/2008
1	Dopamine Receptors (Dopamine Receptor)IBA 10/2008
1	Arginine (L-Arginine)FDA Link 08/2008
1	Hormones (Hormone)IBA 08/2008
1	GhrelinIBA 08/2008
1	potassium perchlorate FDA Link 06/2008
1	CreatinineIBA 06/2008
1	Riluzole FDA LinkGeneric 10/2007
1	Androgen Antagonists (Antiandrogens)IBA 07/2004
1	Estrogens (Estrogen)FDA Link 07/2004
1	Glucose (Dextrose)FDA LinkGeneric 02/2003
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2003
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2003
1	Prostate-Specific Antigen (Semenogelase)IBA 10/2002
1	Insulin (Novolin)FDA Link 04/2002
1	Anterior Pituitary HormonesIBA 03/2002
1	Thyroxine (Levothyroxine)FDA LinkGeneric 05/2001
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 05/2001
1	Reverse TriiodothyronineIBA 05/2001
1	Thyroid HormonesIBA 05/2001
1	IodineIBA 05/2001
1	Iodide Peroxidase (Deiodinase)IBA 05/2001
1	Pharmaceutical PreparationsIBA 05/2001
1	Dehydroepiandrosterone SulfateIBA 01/2000
1	Dehydroepiandrosterone (DHEA)IBA 01/2000

Therapy/Procedure

6	Therapeutics 12/2017 - 06/2004
1	Biological Therapy 12/2017
1	Radiotherapy 06/2004